Immuneering (IMRX) Gross Profit (2020 - 2022)
Immuneering (IMRX) posted quarterly Gross Profit of $455.0 for Q4 2022, up 102.74% year-over-year from $224.43 in Q4 2021, and down 97.61% quarter-over-quarter from $19037.0 in Q3 2022.
Immuneering (IMRX) Gross Profit (2020 - 2022) Analysis & Trends
Immuneering's Gross Profit history runs 3 years deep, the most recent figure standing at $455.0 for Q4 2022.
- In Q4 2022, Gross Profit rose 102.74% year-over-year to $455.0; the TTM figure through Sep 2023 stood at $455.0 (down 99.68% YoY), while the FY2022 annual figure was $158830.0, down 82.86% from the prior year.
- Gross Profit for Q4 2022 stood at $455.0, down from $19037.0 in the prior quarter.
- The five-year high for Gross Profit was $367568.0 in Q3 2020, with the low at -$16630.0 in Q4 2021.
- The 3-year median for Gross Profit is $191847.0 (2020), against an average of $171718.7.
- The sharpest annual moves came in 2021 and 2022: Gross Profit slumped 108.67% in 2021, then soared 102.74% in 2022.
- Immuneering's Gross Profit stood at $191847.0 in 2020, then slumped by 108.67% to -$16630.0 in 2021, then jumped by 102.74% to $455.0 in 2022.
- Business Quant data shows IMRX's Gross Profit at $455.0 in Q4 2022, $19037.0 in Q3 2022, and $46486.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Immuneering | 327.37 Mn | 327.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 455.00 |
| Dec 31, 2022 | 455.00 |
| Sep 30, 2022 | 19,037.00 |
| Sep 30, 2022 | 19,037.00 |
| Jun 30, 2022 | 46,486.00 |
| Jun 30, 2022 | 46,486.00 |
| Mar 31, 2022 | 92,852.00 |
| Mar 31, 2022 | 92,852.00 |
| Dec 31, 2021 | -16,630.00 |
| Dec 31, 2021 | -16,630.00 |
| Sep 30, 2021 | 263,042.00 |
| Sep 30, 2021 | 263,042.00 |
| Jun 30, 2021 | 341,439.00 |
| Jun 30, 2021 | 341,439.00 |
| Mar 31, 2021 | 339,037.00 |
| Mar 31, 2021 | 339,037.00 |
| Dec 31, 2020 | 191,847.00 |
| Dec 31, 2020 | 191,847.00 |
| Sep 30, 2020 | 367,568.00 |
| Sep 30, 2020 | 367,568.00 |